Market Cap 622.59M
Revenue (ttm) 65.12M
Net Income (ttm) -54.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -84.09%
Debt to Equity Ratio 0.00
Volume 497,500
Avg Vol 548,148
Day's Range N/A - N/A
Shares Out 43.36M
Stochastic %K 70%
Beta N/A
Analysts Strong Sell
Price Target $25.00

Latest News on BBNX

Beta Bionics, Inc. (BBNX) Q1 2025 Earnings Call Transcript

May 10, 2025, 10:05 AM EDT - 9 days ago

Beta Bionics, Inc. (BBNX) Q1 2025 Earnings Call Transcript


Beta Bionics: Slowing Down Or Being Conservative?

Apr 24, 2025, 11:44 AM EDT - 25 days ago

Beta Bionics: Slowing Down Or Being Conservative?


Beta Bionics to Host Investor Event on June 22, 2025

Apr 9, 2025, 7:30 AM EDT - 5 weeks ago

Beta Bionics to Host Investor Event on June 22, 2025


Beta Bionics Announces Board Appointment of Gerard Michel

Mar 27, 2025, 4:45 PM EDT - 7 weeks ago

Beta Bionics Announces Board Appointment of Gerard Michel


Beta Bionics: A Sugar Rush For This IPO

Feb 2, 2025, 9:43 AM EST - 3 months ago

Beta Bionics: A Sugar Rush For This IPO


Beta Bionics Aims For IPO To Cover Heavy Losses

Jan 10, 2025, 11:36 AM EST - 4 months ago

Beta Bionics Aims For IPO To Cover Heavy Losses


Beta Bionics IPO Registration Document (S-1)

Jan 6, 2025, 4:25 PM EST - 4 months ago

Beta Bionics IPO Registration Document (S-1)